NASDAQ: NAKA
Kindly MD Inc Earnings Dates, Reports, Calls

Kindly MD earnings were -$4.4M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NAKA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.0M, up 3.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NAKA reported annual earnings of -$3.6M, with 123.7% growth.

NAKA earnings history

Current Revenue
$2.5M
Current Earnings
-$4.4M
Current Profit Margin
-177%

NAKA Return on Equity

Current Company
-146.2%
Current Industry
10.1%
Current Market
32.1%
NAKA's Return on Equity (-146.2%)... subscribe to Premium to read more.
High Return on Equity Performance

NAKA undefined

Current Company
-109.2%
Current Industry
5.3%
NAKA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NAKA announces earnings.

NAKA undefined

Current Company
-201.42%
Current Industry
9.5%

NAKA vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NAKA-$3.78M-$4.37MN/A-$0.77
EUDA-$15.14M-$15.36MN/A-$0.47
AMWL-$120.16M-$154.74MN/A-$10.17
OWLT-$9.20M-$17.37MN/A-$1.58
SYN/A-$82.96MN/A-$0.81

Kindly MD Earnings Reports & History FAQ

What were Kindly MD's earnings last quarter?

Kindly MD (NASDAQ: NAKA) reported Q1 2025 earnings per share (EPS) of -$0.17, up 183.33% year over year. Total NAKA earnings for the quarter were -$1.04 million. In the same quarter last year, Kindly MD's earnings per share (EPS) was -$0.06.

If you're new to stock investing, here's how to buy Kindly MD stock.

Is Kindly MD profitable or losing money?

As of the last Kindly MD earnings report, Kindly MD is currently losing money. Kindly MD's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$4.37 million, a 154.44% increase year over year.

What was NAKA's earnings growth in the past year?

As of Kindly MD's earnings date in Q2 2025, Kindly MD's earnings has grown year over year. NAKA earnings in the past year totalled -$4.37 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.